New Jersey-based Legend Biotech announced its Q2 earnings on Monday, reporting $439m of revenues for its only commercial product, the cell therapy Carvykti. Carvykti leads CAR-T therapy sales with ...

Infinitus, healthcare's agentic communications platform, today announced FieldForce, a new set of secure AI agents designed to extend the capacity of pharmaceutical field teams. Pharma companies can ...

Krystal Biotech KRYS reported first-quarter 2026 earnings per share (EPS) of $1.83, which surpassed the Zacks Consensus Estimate of $1.45. The reported EPS was up from $1.20 in the year-ago quarter.

In today’s unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability. That means turning to assets that can hold up under pressure, especially those ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Biotech stock Zai Lab (ZLAB) slipped as investors digested the company's mixed fourth-quarter earnings report early Thursday. The stock is approaching a buy point. Zai Lab — Thursday's pick for IBD 50 ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

The macroenvironment in 2025 looks grim as signs of a slowdown in the economy set in. The biotech industry experienced a choppy ride in 2024, and the same is likely in store in 2025. Given the ...

Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology fundraising after turbulence in the sector last year. Aided by a rebound in ...

Nurse.org interviewed Keith Dawson, DNP, MS, RN, Senior Director, Global Population Science, Genentech (A Member of the Roche ...